Author Post | AI In Clinical Trials: Technology Is Only As Good As The People Behind It
June 11, 2026
In this article, Gary Zammit, PhD, explores how artificial intelligence is reshaping the clinical trial lifecycle—from drug discovery and protocol design to patient selection, monitoring, and data management—driving faster, more data-driven decision-making, improved efficiency, and enhanced outcomes through advanced analytics and automation. However, AI is not a substitute for human expertise. Its impact depends on how effectively it is implemented, validated, and interpreted by experienced professionals. Striking the right balance between AI capabilities and human judgment remains essential to ensuring reliable, ethical, and successful clinical development.
